Job Cuts As Nordic Nanovector Extends Cash Runway

Biotech’s Priority Is Pivotal Betalutin Study But COVID-19 Uncertainty Remains

 
• By Sten Stovall
  
Runway_24
Nordic Nanovector has extended its cash runway by restructuring, cutting costs. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip